InsiderSignal.AI

InsiderSignal.ai

AORT - Artivion, Inc.

Insider Sale by Stanton Marshall S. (SVP, Clinical, MD Affair)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Stanton Marshall S., serving as SVP, Clinical, MD Affair at Artivion, Inc. (AORT), sold 2,149 shares at $37.78 per share, for a total transaction value of $81,180.00. Following this transaction, Stanton Marshall S. now holds 60,097 shares of AORT.

This sale represents a 3.00% decrease in Stanton Marshall S.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 1 day after the trade was made.

Artivion, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Stanton Marshall S.

SVP, Clinical, MD Affair

Marshall S. Stanton, M.D. is a corporate insider at Artivion, Inc. (AORT), serving as Senior Vice President, Clinical Research and Chief Medical Officer.[[1]](https://fintool.com/app/research/companies/AORT/people/marshall-s-stanton)[[5]](https://artivion.com/about/) He recently sold 2,423 shares of AORT stock on February 25, 2026.[[3]](https://www.marketbeat.com/instant-alerts/artivion-nyseaort-svp-marshall-stanton-sells-2423-shares-2026-02-25/) Stanton notified the company of his retirement effective March 31, 2026, after nearly five years of service, during which Artivion achieved significant growth including 9.4% constant-currency revenue growth and $71.3 million adjusted EBITDA in 2024, alongside a nearly 60% stock price increase.[[1]](https://fintool.com/app/research/companies/AORT/people/marshall-s-stanton) His tenure contributed to Artivion's advancements in aortic disease treatments, including products like On-X valves and JOTEC stent grafts.[[1]](https://fintool.com/app/research/companies/AORT/people/marshall-s-stanton)[[2]](https://dcfmodeling.com/blogs/history/aort-history-mission-ownership) Details on prior roles or education are not specified in available sources, though his M.D. designation indicates medical training.[[1]](https://fintool.com/app/research/companies/AORT/people/marshall-s-stanton)[[5]](https://artivion.com/about/)

View full insider profile →

Trade Price

$37.78

Quantity

2,149

Total Value

$81,180.00

Shares Owned

60,097

Trade Date

Tuesday, March 3, 2026

2 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Artivion, Inc.

Company Overview

No company information available
View news mentioning AORT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4499762

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime